ABALOPARATIDE - Food and Drug Administration
- Set ID
- a7094e2c-eaa7-46d9-a698-6fbd244cb6ae
- Type
- Indexing - product concept
- Effective date
- 2017-07-06
- Version
- 1
- Source
- DailyMed source
Mapped DailyMed Labels#
| Label | Relation | Manufacturer | Effective |
|---|---|---|---|
| These highlights do not include all the information needed to use TYMLOS safely and effectively. See full prescribing information for TYMLOS. TYMLOS ® (abaloparatide) injection, for subcutaneous use Initial U.S. Approval: 2017 | Product name | Radius Health, Inc. | PolyPeptide SA | Vetter Pharma-Fertigung GmbH & Co. KG | Novocol Pharmaceuticals of Canada, Inc | 2026-08-11 |
| These highlights do not include all the information needed to use TYMLOS safely and effectively. See full prescribing information for TYMLOS. TYMLOS ® (abaloparatide) injection, for subcutaneous use Initial U.S. Approval: 2017 | Product name | Radius Health, Inc. | PolyPeptide SA | Vetter Pharma-Fertigung GmbH & Co. KG | Novocol Pharmaceuticals of Canada, Inc | 2025-04-04 |